minor
groov
binder
mgb
probe
assay
develop
discrimin
type
vaccin
field
strain
canin
parvoviru
cpv
consid
cpv
vaccin
contain
old
type
longer
circul
canin
popul
two
mgb
probe
specif
antigen
variant
type
respect
label
differ
fluorophor
mgb
probe
assay
abl
discrimin
correctli
old
type
variant
detect
limit
dna
copi
good
reproduc
quantit
viral
dna
load
accur
demonstr
compar
cpv
dna
titr
calcul
mean
taqman
assay
recognis
cpv
type
assay
ensur
resolut
diagnost
problem
dog
show
cpv
diseas
shortli
cpv
vaccin
although
discrimin
field
strain
type
vaccin
recent
licens
market
countri
canin
parvoviru
type
respons
acut
sometim
fatal
gastroenter
dog
carmichael
binn
emerg
late
kelli
appel
et
al
burtonboy
et
al
johnson
spreadbrow
replac
year
antigen
variant
parrish
et
al
parrish
et
al
parrish
et
al
current
three
main
antigen
variant
known
name
type
various
distribut
dog
popul
worldwid
mochizuki
et
al
de
ybanez
et
al
greenwood
et
al
truyen
et
al
truyen
et
al
steinel
et
al
sagazio
et
al
buonavoglia
et
al
pereira
et
al
buonavoglia
et
al
martella
et
al
desario
et
al
decaro
et
al
decaro
et
al
c
design
previous
cpv
mutant
emerg
itali
detect
countri
nakamura
et
al
moreov
pathogen
investig
decaro
et
origin
type
although
disappear
field
still
present
vaccin
avail
market
parrish
et
al
tradit
identif
variant
carri
mean
timeconsum
techniqu
haemagglutin
inhibit
hi
test
monoclon
antibodi
mab
parrish
carmichael
nakamura
et
al
pcrrflp
enzym
mboii
pcrbase
method
pereira
et
al
sequenc
analysi
often
requir
use
combin
method
definit
predict
antigen
specif
recent
two
realtim
pcr
assay
use
minor
groov
binder
mgb
probe
develop
rapid
unambigu
characteris
decaro
et
al
decaro
et
al
mgb
probe
assay
abl
recognis
singl
nucleotid
polymorph
snp
exist
type
type
determin
presenc
residu
capsid
protein
amino
acid
asn
asp
glu
type
respect
parrish
et
al
buonavoglia
et
al
tabl
type
type
assay
found
highli
sensit
specif
although
type
probe
abl
discrimin
type
cpv
orig
inal
type
fact
type
present
nucleotid
posit
viral
genom
old
type
characteris
erron
type
use
mgb
strategi
decaro
et
al
decaro
et
al
make
type
mgb
probe
assay
inadequ
discrimin
dog
vaccin
origin
type
dog
infect
type
although
note
vaccin
viru
shed
faec
low
titr
shorter
time
period
field
strain
usual
diagnost
test
carri
faec
sick
anim
decaro
et
al
problem
may
occur
especi
test
faecal
sampl
collect
dog
display
diarrhoea
day
administr
type
vaccin
crucial
abl
detect
differenti
vaccin
viru
field
strain
effort
develop
mgb
probe
assay
rapid
discrimin
vaccin
old
type
field
type
strain
total
sampl
test
consist
sampl
posit
origin
type
sampl
posit
antigen
variant
type
n
type
n
type
n
predict
cpv
specif
carri
hi
test
mab
parrish
carmichael
nakamura
et
al
pcrrflp
enzym
mboii
sequenc
analysi
describ
desario
et
al
sampl
contain
antigen
variant
recruit
previou
studi
desario
et
al
sinc
old
type
longer
circul
dog
popul
sampl
contain
includ
follow
vaccin
formul
licens
itali
vanguard
vanguard
cpv
pfizer
inc
ny
usa
tetradogchpl
parvodogp
primodog
merial
italia
spa
milan
itali
nobivac
ceppi
nobivac
parvoc
nobivac
puppi
cp
intervet
italia
srl
milan
itali
canigen
ceppil
virbac
srl
milan
itali
experiment
type
vaccin
buonavoglia
et
al
also
test
commerci
vaccin
three
dose
differ
batch
test
separ
run
faecal
sampl
homogenis
wv
phosphat
buffer
salin
pb
ph
subsequ
clarifi
centrifug
g
min
dna
extract
supernat
boil
faecal
homogen
min
chill
ice
schunck
et
al
uwatoko
et
al
lyophilis
vaccin
resuspend
ml
pb
process
faecal
homogen
reduc
residu
inhibitor
dna
polymeras
activ
ineffect
concentr
dna
extract
dilut
distil
water
decaro
et
al
decaro
et
al
standard
dna
old
type
field
strain
type
obtain
vaccin
vanguard
cpv
pfizer
italia
srl
rome
itali
field
faecal
sampl
characteris
type
decaro
et
al
respect
order
increas
viral
dna
titr
vaccin
strain
passag
three
time
canin
cell
line
dna
load
vaccin
field
virus
calcul
use
realtim
pcr
assay
abl
recognis
strain
decaro
et
al
tenfold
dilut
standard
dna
carri
cpvneg
faecal
suspens
aliquot
dilut
frozen
c
use
primer
mgb
probe
specif
vaccin
wild
type
design
synthesis
appli
biosystem
foster
citi
ca
take
account
snp
encount
capsid
protein
gene
origin
type
variant
respons
chang
ile
thr
residu
capsid
protein
martella
et
al
press
tabl
probe
specif
vaccin
field
strain
label
fam
vic
fluorophor
respect
specif
sequenc
posit
realtim
pcr
primer
mgb
probe
report
tabl
realtim
pcr
conduct
icycl
iq
tm
realtim
detect
system
biorad
laboratori
srl
milan
itali
reaction
l
contain
l
templat
standard
dna
l
iq
tm
supermix
biorad
laboratori
srl
nm
primer
nm
probe
cpvvpb
two
differ
well
use
test
sampl
dilut
standard
dna
activ
itaq
dna
polymeras
c
min
cycl
twostep
pcr
perform
consist
denatur
c
primer
annealingextens
c
min
increas
fluoresc
signal
regist
annealingextens
step
reaction
data
analys
appropri
sequenc
detector
softwar
version
serial
log
dilut
standard
dna
type
type
carri
cpvneg
faecal
suspens
use
determin
detect
linear
assay
sinc
vaccin
viru
found
dna
titr
lower
respect
field
cpv
standard
dna
concentr
rang
dna
l
templat
type
respect
c
valu
measur
triplic
plot
log
input
dna
copi
number
specif
assay
evalu
process
high
low
concentr
dna
origin
type
type
well
dna
prepar
four
unrel
dna
virus
dog
includ
minut
viru
canin
decaro
et
al
canid
herpesviru
decaro
et
al
canin
adenoviru
type
type
decaro
et
al
steril
water
intraassay
interassay
reproduc
evalu
use
high
intermedi
low
input
standard
dna
old
type
dilut
cpvneg
faecal
suspens
coeffici
variat
absolut
copi
number
obtain
dilut
calcul
describ
previous
decaro
et
al
decaro
et
al
order
determin
abil
quantifi
correctli
discrimin
vaccin
field
strain
artifici
gener
dna
mixtur
compos
dna
vaccin
field
strain
variou
concentr
test
mgb
probe
assay
absolut
copi
number
type
calcul
dna
extract
process
parallel
taqman
assay
abl
recognis
old
type
antigen
variant
decaro
et
al
assay
intern
control
use
exogen
dna
nucleic
acid
extract
ovin
herpesviru
type
decaro
et
al
realtim
pcr
carri
l
reaction
contain
l
master
mix
biorad
laboratori
srl
nm
primer
cpvfor
cpvrev
nm
probe
cpvpb
tabl
l
dna
follow
thermal
protocol
use
activ
itaq
dna
polymeras
c
min
cycl
consist
denatur
c
primer
anneal
c
extens
c
min
detect
limit
mgb
probe
assay
shown
dna
copi
type
standard
curv
demonstr
strong
linear
correl
copi
type
copi
type
fig
crossreact
observ
old
type
variant
fam
fluoresc
signal
gener
dna
templat
vaccin
origin
type
wherea
vic
fluoresc
regist
dna
prepar
wild
type
test
furthermor
none
four
fig
coeffici
variat
intraassay
interassay
dynam
rang
type
mgb
probe
assay
canin
virus
show
crossreact
well
fam
vic
fluoresc
obtain
steril
water
cv
intraassay
rang
old
type
cv
interassay
slightli
higher
valu
rang
origin
type
type
fig
sampl
spike
low
copi
high
copi
concentr
dna
old
type
variant
show
interfer
detect
quantit
vaccin
field
strain
contain
sampl
dna
titr
calcul
correctli
cpv
type
data
shown
cpv
dna
load
vaccin
field
sampl
calcul
parallel
develop
mgb
probe
assay
taqman
assay
establish
previous
decaro
et
al
shown
fig
two
assay
found
correl
well
share
log
dynam
rang
calcul
similar
dna
titr
sampl
contrast
poor
correl
found
vaccin
titr
report
manufactur
express
ccid
dna
copi
number
calcul
mgb
probe
assay
tabl
diagnosi
cpv
infect
may
ambigu
carri
faecal
sampl
dog
present
diarrhoea
day
vaccin
fact
modifiedl
viru
contain
vaccin
abl
replic
intestin
mucosa
vaccin
dog
carmichael
et
al
buonavoglia
et
al
despit
unnatur
rout
administr
intramuscular
subcutan
instead
oronas
shed
faec
albeit
low
titr
shorter
time
period
respect
field
strain
note
previou
work
decaro
et
al
circumst
detect
nucleic
acid
faec
vaccin
dog
could
provid
falseposit
result
lead
misdiagnosi
diseas
probabl
caus
enter
pathogen
dog
ie
canin
coronaviru
canin
distemp
viru
reovirus
rotavirus
salmonella
spp
etc
moreov
would
import
rule
vaccineinduc
diseas
due
regain
virul
vaccin
old
type
viru
purpos
characteris
cpv
use
tradit
techniqu
often
inconclus
sinc
simultan
infect
type
vaccin
wildtyp
viru
may
mislead
result
hi
mab
pcrrflp
sequenc
analysi
pcrbase
approach
propos
senda
et
al
address
point
take
advantag
two
snp
determin
replac
met
leu
posit
ala
gli
posit
oldand
wildtyp
strain
respect
tabl
two
primer
specif
wild
type
type
select
one
mutat
end
nucleotid
mismatch
occur
end
primer
highli
detriment
primer
extens
strongli
decreas
pcr
amplif
howev
experi
mutat
suffici
prevent
complet
amplif
old
type
viru
vaccin
v
martella
n
decaro
c
buonavoglia
person
observ
moreov
sampl
contain
vaccin
wildtyp
strain
amplifi
success
pcrbase
strategi
abl
detect
simultan
presenc
two
virus
faec
mgb
probe
assay
develop
rapid
characteris
cpv
strain
decaro
et
al
decaro
et
al
discrimin
old
type
type
thu
sampl
collect
vaccin
dog
characteris
type
test
novel
mgb
probe
assay
order
assess
whether
true
type
field
strain
vaccin
old
type
viru
correct
discrimin
help
resolut
diagnost
dilemma
aris
dog
develop
gastroenter
sign
day
cpv
vaccin
old
viru
recent
type
vaccin
licens
avail
market
although
moment
vaccin
use
wide
problem
may
aris
test
sampl
collect
dog
administ
type
vaccin
fact
vaccin
viru
shed
faec
would
recognis
probe
specif
cpv
variant
characteris
field
strain
instead
vaccin
strain
consequ
addit
assay
develop
abl
discrimin
type
vaccin
type
field
cpv
order
obtain
correct
discrimin
dog
vaccin
infect
conclus
test
develop
allow
discrimin
vaccin
virus
field
strain
could
help
correct
diagnosi
dog
display
enter
shortli
administr
type
vaccin
mostli
use
worldwid
